secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001213900-24-004520
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea regains Nasdaq minimum bid price compliance, delisting risk removed
----------------------------------------------------------------------------

- Received Nasdaq letter on Jan 17, 2024 confirming compliance with $1.00 minimum bid price rule.
- Stock held closing bid at or above $1.00 for sufficient consecutive business days to satisfy requirement.
- Previously received non-compliance notice on Jan 19, 2023 and extension to Jan 15, 2024.
- Matter is now closed; no further action needed regarding bid price deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024004520/0001213900-24-004520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024004520/ea191820-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-004520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer